About: Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article; Pure and Applied Chemistry

Attributes	Values
rdf:type	Item
description	ലേഖനം (ml) wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1998 (uk) im Januar 1998 veröffentlichter wissenschaftlicher Artikel (de) scholarly article; Pure and Applied Chemistry (en)
publication date	wds:Q54260077-F301144E-8AC0-4C60-8A6E-5883372E6398
publication date	1998-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q54260077-A98F2B1A-EA42-4F35-8BBA-9783F30E8115 wds:Q54260077-B6DFF971-DB2E-4909-999A-2ECDCDD73924 wds:Q54260077-B7B3B356-2955-45FE-BB33-992783EE5F4A wds:Q54260077-DD70763D-F424-416A-A365-E3B2108B3C7D
author name string	C. R. Ganellin C. G. Wermuth L. A. Mitscher P. Lindberg
rdfs:label	Glossary of terms used in medicinal chemistry (nl) Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998) (en)
skos:prefLabel	Glossary of terms used in medicinal chemistry (nl) Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998) (en)
name	Glossary of terms used in medicinal chemistry (nl) Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998) (en)
title	wds:Q54260077-9AB56F6E-5E2E-4725-9AF8-692F6008C8AA
title	Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998) (en)
page(s)	wds:Q54260077-0D58C701-15D8-4367-B764-96E5CB16C079
page(s)	1129-1143
instance of	wds:Q54260077-5826F0C5-55CD-49D3-B533-7000E8DFCDE7
instance of	scholarly article
published in	wds:Q54260077-28DABEA8-6615-42E3-9074-F09D096B6FFC
published in	Pure and Applied Chemistry
issue	wds:Q54260077-AE25D526-23DF-4FA9-B91D-664DE7BFB0FD
volume	wds:Q54260077-AC9BDA32-A2FE-49BD-A706-457139236AE9
issue	5
volume	70
DOI	wds:Q54260077-BB3AD21D-031D-4148-892B-C284E31504C3
DOI	http://dx.doi.org/10.1351/PAC199870051129
DOI	10.1351/PAC199870051129
Fatcat ID	wds:Q54260077-6AF9FEDB-9D9D-4E38-9367-875609328385
Fatcat ID	release_dgepilblf5ejvkbhd4vsr2riwy
ResearchGate publication ID	wds:Q54260077-71BEC4FD-74E9-4F62-8439-94325B2DCE60
ResearchGate publication ID	244742112
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q54260077
is cites work of	11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approaches Alignment-free ultra-high-throughput comparison of druggable protein-ligand binding sites PENG: a neural gas-based approach for pharmacophore elucidation. method design, validation, and virtual screening for novel ligands of LTA4H Pharmacophore modeling for anti-Chagas drug design using the fragment molecular orbital method Ligand-based pharmacophore modeling and virtual screening for the discovery of novel 17β-hydroxysteroid dehydrogenase 2 inhibitors Carbaboranes as pharmacophores: similarities and differences between aspirin and asborin. Beyond the virtual screening paradigm: structure-based searching for new lead compounds Discovery of new inhibitors of Mycobacterium tuberculosis InhA enzyme using virtual screening and a 3D-pharmacophore-based approach. Carbaboranes as pharmacophores: properties, synthesis, and application strategies Computer-based de novo design of drug-like molecules Relationships between molecular structure and perceived odor quality of ligands for a human olfactory receptor Software and resources for computational medicinal chemistry Comparing pharmacophore models derived from crystal structures and from molecular dynamics simulations Three-dimensional pharmacophore methods in drug discovery In silico methods in the discovery of endocrine disrupting chemicals Natural occurring polyphenols as template for drug design. Focus on serine proteases A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields GeauxDock: A novel approach for mixed-resolution ligand docking using a descriptor-based force field Pharmacophore-based similarity scoring for DOCK Structure-Based Pharmacophores for Virtual Screening A novel synthesized tyrosinase inhibitor: (E)-2-((2,4-dihydroxyphenyl)diazenyl)phenyl 4-methylbenzenesulfonate as an azo-resveratrol analog Anti-inflammatory and antinociceptive activities of LQFM002 - A 4-nerolidylcatechol derivative. Predicting Cyclooxygenase Inhibition by Three-Dimensional Pharmacophoric Profiling. Part I: Model Generation, Validation and Applicability in Ethnopharmacology Advances in cobalt complexes as anticancer agents Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases Methods for generating and applying pharmacophore models as virtual screening filters and for bioactivity profiling Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2. Pharmacophore Model Refinement for 11β-Hydroxysteroid Dehydrogenase Inhibitors: Search for Modulators of Intracellular Glucocorticoid Concentrations. In Silico Predictions of Drug - Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition - a Comparative Study of Virtual Screening Performance Pharmacophore modeling for COX-1 and -2 inhibitors with LigandScout in comparison to Discovery Studio Safranal and its analogs inhibit Escherichia coli ATP synthase and cell growth. Understanding the link between antimicrobial properties of dietary olive phenolics and bacterial ATP synthase. Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development Identification of chemically diverse, novel inhibitors of 17β-hydroxysteroid dehydrogenase type 3 and 5 by pharmacophore-based virtual screening. Terminology for biorelated polymers and applications (IUPAC Recommendations 2012) Construction and assessment of reaction models of class I EPSP synthase: molecular docking and density functional theoretical calculations. Combined pharmacophore and 3D-QSAR study on a series of Staphylococcus aureus Sortase A inhibitors In silico prediction of hERG inhibition A new crystal structure fragment-based pharmacophore method for G protein-coupled receptors ColBioS-FlavRC: a collection of bioselective flavonoids and related compounds filtered from high-throughput screening outcomes Discovery of new inhibitors of Schistosoma mansoni PNP by pharmacophore-based virtual screening. Dibenzo[a,e]pentalenes with Low-Lying LUMO Energy Levels as Potential n-Type Materials. Computational chemical biology and drug design: Facilitating protein structure, function, and modulation studies. Molecular insight on the binding of NNRTI to K103N mutated HIV-1 RT: molecular dynamics simulations and dynamic pharmacophore analysis. Machine learning-, rule- and pharmacophore-based classification on the inhibition of P-glycoprotein and NorA. In silico pharmacology for a multidisciplinary drug discovery process A Smart Europium-Ruthenium Complex as Anticancer Prodrug: Controllable Drug Release and Real-Time Monitoring under Different Light Excitations Bitter taste receptor activation by flavonoids and isoflavonoids: modeled structural requirements for activation of hTAS2R14 and hTAS2R39. Molecular docking simulation, synthesis and 3D pharmacophore studies of novel 2-substituted-5-nitro-benzimidazole derivatives as anticancer agents targeting VEGFR-2 and c-Met. Exploring the structural requirements in multiple chemical scaffolds for the selective inhibition of Plasmodium falciparum calcium-dependent protein kinase-1 (PfCDPK-1) by 3D-pharmacophore modelling, and docking studies. Bioinformatics: A rational combine approach used for the identification and in-vitro activity evaluation of potent β-Glucuronidase inhibitors In silico identification, synthesis and biological evaluation of novel tetrazole inhibitors of MurB. Protein-protein interactions as antibiotic targets: A medicinal chemistry perspective Computational Approaches for Target Inference Pharmacophore model-based virtual screening, docking, biological evaluation and molecular dynamics simulations for inhibitors discovery against α-tryptophan synthase from Mycobacterium tuberculosis Semiempirical Rules To Determine Drug Sensitivity and Ionization Efficiency in Secondary Ion Mass Spectrometry Using a Model Tissue Sample. Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens? TASK Channels Pharmacology: New Challenges in Drug Design

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software